在《终点新闻》 题为《律师们争相为客户应对特朗普100%药品关税威胁提供建议》的报道中,富乐律师事务所合伙人戴维·罗森指出,特朗普总统近期宣布对在美国境外生产的名牌药品征收100%关税后,整个制药行业正面临不确定性。
尽管关税尚未正式实施,且制药公司若在美国境内建设生产设施或可免于缴纳,但该行业正努力评估潜在关税对业务运营的影响。
罗森表示:“我们收到许多疑问,正努力厘清:何为制造业?何为在美国创办制造型初创企业?何为私营新工厂的破土动工?”
人
相关新闻
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
2026年1月2日
新闻速递
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
2026年1月2日
新闻速递
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”